New Eclipsys Clinical Apps Ease Drug Orders

 
 
By M.L. Baker  |  Posted 2005-03-31 Email Print this article Print
 
 
 
 
 
 
 

Latest release reduces the number of clicks physicians need to make to complete an order and automatically adds in billing codes to eliminate additional entries.

Eclipsys Corp. Thursday launched Sunrise 4.0XA, the latest release of its suite of clinical information technology applications, with more than 450 new features in 16 functional areas. John Gomez, the companys chief technology officer, said the new rollout includes faster and more powerful physician documentation, allowing orders for drugs and procedures to be linked and managed in more complex ways. In addition, default settings for long-term diseases, particularly cancer, adapt for different stages of disease.
The idea was to enable doctors to complete tasks with "the least possible amount of interaction with the device," Gomez said, so the new version reduces the number of clicks physicians need to make to complete an order and adds in billing codes automatically to eliminate additional entries.
Many of the new features stemmed from extensive collaboration with customers, Gomez said. Customers participated online, in person, and over the phone. "We had a fake hospital that customers could log into from their hospital, and essentially become part of the QA team," he said. In addition, clinicians from different hospitals worked directly with the software development team. The "customers really wanted to participate," Gomez said, adding that he was surprised at how willing they were to travel and stay involved. Read the full story on CIO Insight: New Eclipsys Clinical Apps Ease Drug Orders
Check out eWEEK.coms for the latest news, views and analysis of technologys impact on health care.
 
 
 
 
Monya Baker is co-editor of CIOInsight.com's Health Care Center. She has written for publications including the journal Nature Biotechnology, the Acumen Journal of Sciences and the American Medical Writers Association, among others, and has worked as a consultant with biotechnology companies. A former high school science teacher, Baker holds a bachelor's degree in biology from Carleton College and a master's of education from Harvard.
 
 
 
 
 
 
 

Submit a Comment

Loading Comments...

 
Manage your Newsletters: Login   Register My Newsletters























 
 
 
 
 
 
 
 
 
 
 
Rocket Fuel